510(k) Report

510(k) · Cleared

Cleared

Vitala Natural Resorbable Collagen Membrane

K101453510(k) TraditionalCleared Jul 21, 2011422-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Obi Biologics, Inc. · NPL Barrier, Animal Source, Intraoral

Cleared on Jul 21, 2011 as substantially equivalent to K050446 (Ed. Geistlich Soehne AG Fuer Chemische Industrie, 2005) and 2 other predicates after a 422-day review. Its family tree reaches back 4 generations to 1995. 4 later devices descend from it.

Decided
Jul 21, 2011
Review
422 days
Class
Class II
Product code
NPL
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K924408 (1995). 7 ancestors in all. 4 later devices descend from it, 1 citing it directly.

  1. Root · 4 generations backK924408 Colla-Tec Absorbable Collagen MembraneColla-Tec, Inc. · 1995 · Recalled
  2. 3 generations backK992216 Biomend Extend Absorbable Collagen Membrane, Biomend Absorbable…Integra Lifesciences Corp. · 1999 · Recalled
  3. 2 generations backK042197 Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone…Ed. Geistlich Soehne AG Fuer Chemische Industrie · 2004
  4. 1 generation backK050446 Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and BoneEd. Geistlich Soehne AG Fuer Chemische Industrie · 2005
  5. This deviceK101453 Vitala Natural Resorbable Collagen MembraneObi Biologics, Inc. · 2011
  6. Descendant · cites it directly · 3 of its ownK141177 Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi · 2015
  7. Descendant · 2 generations on · 2 of its ownK173562 Straumann Jason MembraneInstitut Straumann AG · 2018
  8. Descendant · 3 generations on · 0 of its ownK242817 Jason membraneBotiss Biomaterials GmbH · 2025
  9. Descendant · 3 generations on · 0 of its ownK223912 InterCollagen® GuideSigmagraft, Inc. · 2023

Most influential descendants

Showing 4 of 4 · See all
  • K141177Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi · 2015 · cites it directly3descendants
  • K173562Straumann Jason MembraneInstitut Straumann AG · 2018 · 2 generations on2descendants
  • K242817Jason membraneBotiss Biomaterials GmbH · 2025 · 3 generations on0descendants
  • K223912InterCollagen® GuideSigmagraft, Inc. · 2023 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K924408Colla-Tec Absorbable Collagen MembraneColla-Tec, Inc.19952
−3K992216Biomend Extend Absorbable Collagen Membrane, Biomend Absorbable Collagen…Integra Lifesciences Corp.19991
−2K042197Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone RegenerationEd. Geistlich Soehne AG Fuer Chemische Industrie2004—
−1K050446Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and BoneEd. Geistlich Soehne AG Fuer Chemische Industrie2005—
0 (this device)K101453Vitala Natural Resorbable Collagen MembraneObi Biologics, Inc.2011—
+1K141177Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi2015—
+2K173562Straumann Jason MembraneInstitut Straumann AG2018—
+3K242817Jason membraneBotiss Biomaterials GmbH2025—
+3K223912InterCollagen® GuideSigmagraft, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200610
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
201810
202310
202510
FIG. 1 — Lineage of K101453, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NPL device

  1. #1 K212463 Geistlich Bio-Gide, Geistlich Bio-Gide Shape…score 14.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K050446Bio-Gide Resorbable Bilayer Membrane for Guided Tissue and Bone
Summary page 1
…ls Guidance Document: Dental Bone Grafting Material Device) Predicate Devices: BiO-GIDE' (1(050446) CopiM Pericardium Membrane (K(073097) Device Description…
Ed. Geistlich Soehne AG Fuer Chemische Industrie2005—
*K073097Tutodent Dental Membrane
Summary page 1
…Device) Predicate Devices: BiO-GIDE' (1(050446) CopiM Pericardium Membrane (K(073097) Device Description Osxh Pu K520 Vital" Resorbable Natural Collagen Membrane isa natural collagen…
Tutogen Medical U.S., Inc.2008—
*K053260Ossix -Plus
Summary page 2
…'-Plus (1(101453) (1(050446) (100730971 (1(053260) Os1Biologics, Inc. -Geistlich-pharm, RT Bi…
Colbar Lifescience, Ltd.2006—

Also cleared against K050446: 16 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141177Vitala Porcine Derived Collagen MembraneOsteogenics Biomedical, Inc. (Formerly Obi Biologi20153

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 4 companies; a new generation was cleared every 5.3 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • Of its descendants, K141177 (Osteogenics Biomedical, Inc. (Formerly Obi Biologi, 2015) has gone furthest, with 3 descendants of its own.
  • 16 other devices also cite its predicate K050446.

How does its category compare?

All NPL devices

NPL Barrier, Animal Source, Intraoral: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NPL

5in 2025

2007: 12008: 42009: 32010: 22011: 42013: 22014: 52015: 12016: 32017: 32018: 12019: 12020: 22021: 22022: 32023: 22024: 32025: 5
2007high 5 (2014) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPL

132in 2025

2008: 172 days median2009: 193 days median2011: 286 days median2014: 140 days median2016: 184 days median2017: 200 days median2022: 290 days median2024: 263 days median2025: 132 days median
2007high 290 (2022) · low 132 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NPL

6in 2019

2012: 32019: 6
2007high 6 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPL

39in 2025

2012: 32013: 22014: 32015: 52016: 92017: 182018: 142019: 222020: 82021: 112022: 192023: 52024: 202025: 39
2007high 39 (2025) · low 0 (2007)2025

MAUDE reports naming product code NPL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008417200
2009319300
20102—00
2011428600
20120—33
20132—02
2014514003
20151—05
2016318409
20173200018
20181—014
20191—622
20202—08
20212—011
20223290019
20232—05
20243263020
20255132039
20260—0—

What is it indicated for?

Vitala Resorbable Natural Collagen Membrane is intended for use during the process of guided bone regeneration (GBR) and guided tissue regeneration (GTR) as a biodegradable barrier for: * Simultaneous use with implants; * Augmentation around implants placed in immediate extraction sockets; * Augmentation around implants placed in delayed extraction sockets; * Localized ridge augmentation for later implantation; * Alveolar ridge reconstruction for…

Read the full statement (144 words)

Vitala Resorbable Natural Collagen Membrane is intended for use during the process of guided bone regeneration (GBR) and guided tissue regeneration (GTR) as a biodegradable barrier for:

* Simultaneous use with implants;

* Augmentation around implants placed in immediate extraction sockets;

* Augmentation around implants placed in delayed extraction sockets;

* Localized ridge augmentation for later implantation;

* Alveolar ridge reconstruction for prosthetic treatment;

* Alveolar ridge preservation consequent to tooth extraction;

* Filling of bone defects after root resection, cystectomy, removal of retained teeth;

* Over the window in lateral window sinus elevation procedures;

* Furcation defects in multi-rooted teeth;

* Treatment of recession defects, together with coronally positioned flap;

* In implants with vertical bone loss due to infection, only with satisfactory debridement and implant surface disinfection;

* Guided bone regeneration in dehiscence defects; and

* Guided tissue regeneration in periodontal defects.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101453: Vitala Natural Resorbable Collagen Membrane.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K101453

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026